YCCI Interim Director, Dr. David Coleman, recipient of the 2023 Larry Zaroff Man of Good Conscious Award
New Interim Director of YCCI David Coleman, MD, Research Professor of Medicine, Emeritus Professor, Yale School of Medicine, is a recipient of the 2023 Larry Zaroff Man of Good Conscious Award from the American Medical Women’s Association. The Association presents this award annually to a man who has been a champion and supporter of women in medicine.
Artificial sweetener linked to higher heart attack risk, study says
The popular artificial sweetener erythritol, which is used as a sugar substitute in many low-calorie, low-carb and keto products, has been linked to heightened risk of heart attack, stroke and death, according to a study published in Nature Medicine.Source: The Washington Post
Applications Open for Fund to Retain Clinical Scientists at the Yale School of Medicine (FRCS)
We are writing to announce a request for applications for supplemental research support from early-career physician-scientists and scientists who face significant caregiving demands. The goal of the program is to retain such scientists in the research enterprise. Funding is provided by the Fund to Retain Clinical Scientists at the Yale School of Medicine (FRCS), funded by the Doris Duke Charitable Foundation, and the Yale School of Medicine. Our process will consider the degree of demonstrated caregiving burden and prioritize applicants with limited access to other resources, such as institutional support packages. Funds can be used to “buy out” clinical obligations or to hire additional research staff to optimize research activities.
Cracking Peanuts and the Code to Wilson Disease
Warren is the first person in the world to receive a groundbreaking treatment for this rare, serious genetic condition, Wilson Disease, in which excessive amounts of copper accumulates in the body, particularly in the liver and brain. Wilson Disease can cause liver and neurological damage, as well as psychiatric issues with memory, impulse control, and anger. A strong, long-term relationship between Warren and Professor of Medicine Michael Schilsky, MD, the physician who is investigating this treatment, has been essential to this novel treatment which has the potential to help patients all over the world.
Yale Study Links Genetics and Blood Pressure Control in Stroke Survivors
Stroke survivors face an increased risk of suffering a second stroke and developing cognitive disabilities as a result. Evidence indicates that hypertension plays a significant role in this comorbidity, and yet, only 60% of stroke survivors have their blood pressure under control. A Yale-led study studies the link between elevated genetic predisposition to hypertension and more-difficult-to-control blood pressure.